PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
INSP vs. RMD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between INSP and RMD is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

INSP vs. RMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Inspire Medical Systems, Inc. (INSP) and ResMed Inc. (RMD). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%40.00%50.00%AugustSeptemberOctoberNovemberDecember2025
23.61%
18.57%
INSP
RMD

Key characteristics

Sharpe Ratio

INSP:

-0.08

RMD:

1.13

Sortino Ratio

INSP:

0.37

RMD:

1.84

Omega Ratio

INSP:

1.06

RMD:

1.26

Calmar Ratio

INSP:

-0.09

RMD:

1.02

Martin Ratio

INSP:

-0.20

RMD:

7.03

Ulcer Index

INSP:

26.03%

RMD:

5.94%

Daily Std Dev

INSP:

67.60%

RMD:

37.05%

Max Drawdown

INSP:

-61.59%

RMD:

-61.60%

Current Drawdown

INSP:

-45.51%

RMD:

-17.04%

Fundamentals

Market Cap

INSP:

$5.32B

RMD:

$35.20B

EPS

INSP:

$1.10

RMD:

$7.54

PE Ratio

INSP:

161.53

RMD:

31.80

Total Revenue (TTM)

INSP:

$563.09M

RMD:

$3.64B

Gross Profit (TTM)

INSP:

$476.09M

RMD:

$2.10B

EBITDA (TTM)

INSP:

$8.27M

RMD:

$1.29B

Returns By Period

In the year-to-date period, INSP achieves a -4.15% return, which is significantly lower than RMD's 4.85% return.


INSP

YTD

-4.15%

1M

-4.97%

6M

23.61%

1Y

-8.09%

5Y*

16.63%

10Y*

N/A

RMD

YTD

4.85%

1M

4.16%

6M

18.57%

1Y

40.09%

5Y*

9.29%

10Y*

16.34%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

INSP vs. RMD — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INSP
The Risk-Adjusted Performance Rank of INSP is 4242
Overall Rank
The Sharpe Ratio Rank of INSP is 4242
Sharpe Ratio Rank
The Sortino Ratio Rank of INSP is 4343
Sortino Ratio Rank
The Omega Ratio Rank of INSP is 4545
Omega Ratio Rank
The Calmar Ratio Rank of INSP is 4141
Calmar Ratio Rank
The Martin Ratio Rank of INSP is 4242
Martin Ratio Rank

RMD
The Risk-Adjusted Performance Rank of RMD is 8181
Overall Rank
The Sharpe Ratio Rank of RMD is 8181
Sharpe Ratio Rank
The Sortino Ratio Rank of RMD is 7878
Sortino Ratio Rank
The Omega Ratio Rank of RMD is 7979
Omega Ratio Rank
The Calmar Ratio Rank of RMD is 8080
Calmar Ratio Rank
The Martin Ratio Rank of RMD is 8686
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

INSP vs. RMD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Inspire Medical Systems, Inc. (INSP) and ResMed Inc. (RMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for INSP, currently valued at -0.08, compared to the broader market-2.000.002.004.00-0.081.13
The chart of Sortino ratio for INSP, currently valued at 0.37, compared to the broader market-4.00-2.000.002.004.000.371.84
The chart of Omega ratio for INSP, currently valued at 1.06, compared to the broader market0.501.001.502.001.061.26
The chart of Calmar ratio for INSP, currently valued at -0.09, compared to the broader market0.002.004.006.00-0.091.02
The chart of Martin ratio for INSP, currently valued at -0.20, compared to the broader market-10.000.0010.0020.00-0.207.03
INSP
RMD

The current INSP Sharpe Ratio is -0.08, which is lower than the RMD Sharpe Ratio of 1.13. The chart below compares the historical Sharpe Ratios of INSP and RMD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50AugustSeptemberOctoberNovemberDecember2025
-0.08
1.13
INSP
RMD

Dividends

INSP vs. RMD - Dividend Comparison

INSP has not paid dividends to shareholders, while RMD's dividend yield for the trailing twelve months is around 0.84%.


TTM20242023202220212020201920182017201620152014
INSP
Inspire Medical Systems, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
RMD
ResMed Inc.
0.84%0.88%1.07%0.83%0.62%0.73%0.98%1.26%1.61%2.03%2.16%1.89%

Drawdowns

INSP vs. RMD - Drawdown Comparison

The maximum INSP drawdown since its inception was -61.59%, roughly equal to the maximum RMD drawdown of -61.60%. Use the drawdown chart below to compare losses from any high point for INSP and RMD. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%AugustSeptemberOctoberNovemberDecember2025
-45.51%
-17.04%
INSP
RMD

Volatility

INSP vs. RMD - Volatility Comparison

Inspire Medical Systems, Inc. (INSP) has a higher volatility of 18.95% compared to ResMed Inc. (RMD) at 7.95%. This indicates that INSP's price experiences larger fluctuations and is considered to be riskier than RMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%AugustSeptemberOctoberNovemberDecember2025
18.95%
7.95%
INSP
RMD

Financials

INSP vs. RMD - Financials Comparison

This section allows you to compare key financial metrics between Inspire Medical Systems, Inc. and ResMed Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab